|Validating the SF-36 health survey questionnaire: new outcome measure for primary care.|
JE Brazier, R Harper, NM Jones, A O'cathain, KJ Thomas, T Usherwood, ...
British medical journal 305 (6846), 160-164, 1992
|The estimation of a preference-based measure of health from the SF-36|
J Brazier, J Roberts, M Deverill
Journal of health economics 21 (2), 271-292, 2002
|Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project|
B Gandek, JE Ware, NK Aaronson, G Apolone, JB Bjorner, JE Brazier, ...
Journal of clinical epidemiology 51 (11), 1171-1178, 1998
|The estimation of a preference-based measure of health from the SF-12|
JE Brazier, J Roberts
Medical care, 851-859, 2004
|Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D|
SJ Walters, JE Brazier
Quality of life research 14 (6), 1523-1532, 2005
|Measuring and valuing health benefits for economic evaluation|
J Brazier, J Ratcliffe, J Saloman, A Tsuchiya
OXFORD university press, 2017
|Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire|
J Brazier, N Jones, P Kind
Quality of Life Research 2 (3), 169-180, 1993
|A comparison of the EQ‐5D and SF‐6D across seven patient groups|
J Brazier, J Roberts, A Tsuchiya, J Busschbach
Health economics 13 (9), 873-884, 2004
|The factor structure of the SF-36 Health Survey in 10 countries: Results from the IQOLA Project|
JE Ware Jr, M Kosinski, B Gandek, NK Aaronson, G Apolone, P Bech, ...
Journal of clinical epidemiology 51 (11), 1159-1165, 1998
|Deriving a preference-based single index from the UK SF-36 Health Survey|
J Brazier, T Usherwood, R Harper, K Thomas
Journal of clinical epidemiology 51 (11), 1115-1128, 1998
|The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA project|
JE Ware Jr, B Gandek, M Kosinski, NK Aaronson, G Apolone, J Brazier, ...
Journal of clinical epidemiology 51 (11), 1167-1170, 1998
|A review of the use of health status measures in economic evaluation|
J Brazier, M Deverill, C Green
Journal of health services research & policy 4 (3), 174-184, 1999
|Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: results from the IQOLA Project|
B Gandek, JE Ware Jr, NK Aaronson, J Alonso, G Apolone, J Bjorner, ...
Journal of clinical epidemiology 51 (11), 1149-1158, 1998
|Evaluating Translations of Health Status Questionnaires: Methods From the IQOLA Project|
JE Ware, SD Keller, B Gandek, JE Brazier, M Sullivan, ...
International journal of technology assessment in health care 11 (3), 525-551, 1995
|Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra|
K Claxton, M Sculpher, C McCabe, A Briggs, R Akehurst, M Buxton, ...
Health economics 14 (4), 339-347, 2005
|Health, health-related quality of life, and quality of life: what is the difference?|
M Karimi, J Brazier
Pharmacoeconomics 34 (7), 645-649, 2016
|A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis|
CA Marra, JC Woolcott, JA Kopec, K Shojania, R Offer, JE Brazier, ...
Social science & medicine 60 (7), 1571-1582, 2005
|A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures|
JE Brazier, Y Yang, A Tsuchiya, DL Rowen
The European journal of health economics 11 (2), 215-225, 2010
|Generic and condition-specific outcome measures for people with osteoarthritis of the knee|
JE Brazier, R Harper, J Munro, SJ Walters, ML Snaith
Rheumatology 38 (9), 870-877, 1999
|What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D|
SJ Walters, JE Brazier
Health and quality of life outcomes 1 (1), 4, 2003